GlassScriptPhysician profile
Paul J Burt
NPI 1902943145
$3,377.45
in general payments reported to CMS, 2019-2025
21 companies · $1,950 in 2025
The $1,950 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $182 · 2021: $53.72 · 2022: $162 · 2023: $350 · 2024: $277 · 2025: $1,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.64 |
| Travel and Lodging | $1,151.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,831.50 | 2022-2025 | Envista Aspire Iol, Vyzulta, Xiidra |
| Alcon Vision LLC | $487.51 | 2019-2025 | Tryptyr, Hydrus Microstent, Eysuvis |
| Abbvie INC. | $153.72 | 2022-2024 | Vuity |
| Novartis Pharmaceuticals Corporation | $147.12 | 2020-2021 | |
| Maculogix, INC. | $98.10 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $86.24 | 2019 | |
| Coopervision INC. | $79.08 | 2019-2025 | Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $78.75 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $57.06 | 2022-2023 | Acuvue |
| Dompe US, INC. | $51.56 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $47.68 | 2022-2023 | Tyrvaya |
| Harrow Eye, LLC | $45.81 | 2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.02 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $35.26 | 2019 | |
| Biotissue Holdings INC. | $33.83 | 2023-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $26.70 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Sun Pharmaceutical Industries INC. | $16.79 | 2025 | |
| Allergan, INC. | $14.28 | 2021 | |
| Abb Con-Cise Optical Group LLC | $13.13 | 2021 | |
| Shire North American Group INC | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Burt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.